Epizyme
Patents, Design & Utilities

Last updated:

List of all Epizyme patents 122 in total

Status Patent
Application
Utility: PEDIATRIC DOSING FOR TREATMENT OF CANCER WITH AN EZH2 INHIBITOR External link
Filling date: 7 Sep 2025 Issue date: 14 Jan 2021
Application
Utility: Methods Of Treating Cancer By Inhibiting SETD2 External link
Filling date: 7 Sep 2025 Issue date: 7 Jan 2021
Grant
Utility: Method of treating leukemia External link
Filling date: 7 Sep 2025 Issue date: 5 Jan 2021
Application
Utility: INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF External link
Filling date: 7 Sep 2025 Issue date: 24 Dec 2020
Application
Utility: INJECTABLE FORMULATIONS FOR TREATING CANCER External link
Filling date: 7 Sep 2025 Issue date: 24 Dec 2020
Application
Utility: SUBSTITUTED BENZENE AND 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS External link
Filling date: 7 Sep 2025 Issue date: 19 Nov 2020
Grant
Utility: Salt form of a human histone methyltransferase EZH2 inhibitor External link
Filling date: 7 Sep 2025 Issue date: 3 Nov 2020
Application
Utility: METHOD OF TREATING CANCER External link
Filling date: 7 Sep 2025 Issue date: 22 Oct 2020
Application
Utility: EZH2 INHIBITORS FOR TREATING LYMPHOMA External link
Filling date: 7 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: METHODS OF TREATING CANCER External link
Filling date: 7 Sep 2025 Issue date: 15 Oct 2020
Grant
Utility: Arginine methyltransferase inhibitors and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 13 Oct 2020
Application
Utility: SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS External link
Filling date: 7 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND DERIVATIVES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 8 Oct 2020
Grant
Utility: Combination therapy for treating cancer External link
Filling date: 7 Sep 2025 Issue date: 29 Sep 2020
Grant
Utility: Method for treating cancer External link
Filling date: 7 Sep 2025 Issue date: 29 Sep 2020
Application
Utility: ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 17 Sep 2020
Application
Utility: METHOD OF TREATING MEDULLOBLASTOMA WITH AN EZH2 INHIBITOR External link
Filling date: 7 Sep 2025 Issue date: 27 Aug 2020
Application
Utility: METHODS OF TREATING CANCER External link
Filling date: 7 Sep 2025 Issue date: 20 Aug 2020
Application
Utility: AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS, SALTS THEREOF, AND METHODS OF SYNTHESIS THEREOF External link
Filling date: 7 Sep 2025 Issue date: 6 Aug 2020
Grant
Utility: Hydrochloride salt form for EZH2 inhibition External link
Filling date: 7 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: Isoxazole carboxamides as irreversible SMYD inhibitors External link
Filling date: 7 Sep 2025 Issue date: 2 Jun 2020
Application
Utility: USE OF EZH2 INHIBITORS FOR TREATING CANCER External link
Filling date: 7 Sep 2025 Issue date: 28 May 2020
Application
Utility: ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS External link
Filling date: 7 Sep 2025 Issue date: 21 May 2020
Application
Utility: METHOD FOR TREATING CANCER External link
Filling date: 7 Sep 2025 Issue date: 21 May 2020
Grant
Utility: PRMT5 inhibitors and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 19 May 2020
Application
Utility: ISOXAZOLE CARBOXAMIDE COMPOUNDS External link
Filling date: 7 Sep 2025 Issue date: 14 May 2020
Application
Utility: METHOD OF TREATING MALIGNANT RHABDOID TUMOR OF THE OVARY (MRTO)/SMALL CELL CANCER OF THE OVARY OF THE HYPERCALCEMIC TYPE(SCCOHT) WITH AN EZH2 INHIBITOR External link
Filling date: 7 Sep 2025 Issue date: 7 May 2020
Grant
Utility: CARM1 inhibitors and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 28 Apr 2020
Grant
Utility: Arginine methyltransferase inhibitors and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 28 Apr 2020
Application
Utility: Substituted Cyclohexylamine Compounds External link
Filling date: 7 Sep 2025 Issue date: 23 Apr 2020
Application
Utility: DOT1L INHIBITORS FOR USE IN THE TREATMENT OF LEUKEMIA External link
Filling date: 7 Sep 2025 Issue date: 16 Apr 2020
Application
Utility: COMBINATION THERAPY FOR TREATING CANCER External link
Filling date: 7 Sep 2025 Issue date: 16 Apr 2020
Application
Utility: METHODS OF USING EHMT2 INHIBITORS External link
Filling date: 7 Sep 2025 Issue date: 16 Apr 2020
Application
Utility: COMBINATION THERAPY FOR TREATING CANCER External link
Filling date: 7 Sep 2025 Issue date: 2 Apr 2020
Application
Utility: SUBSTITUTED PYRROLIDINE COMPOUNDS External link
Filling date: 7 Sep 2025 Issue date: 2 Apr 2020
Application
Utility: COMBINATION THERAPY FOR TREATING CANCER External link
Filling date: 7 Sep 2025 Issue date: 12 Mar 2020
Application
Utility: INHIBITION OF SMARCA2 FOR TREATMENT OF CANCER External link
Filling date: 7 Sep 2025 Issue date: 5 Mar 2020
Grant
Utility: Substituted piperidine compounds External link
Filling date: 7 Sep 2025 Issue date: 3 Mar 2020
Application
Utility: COMBINATION THERAPIES WITH EHMT2 INHIBITORS External link
Filling date: 7 Sep 2025 Issue date: 20 Feb 2020
Application
Utility: SUBSTITUTED PYRROLIDINE CARBOXAMIDE COMPOUNDS External link
Filling date: 7 Sep 2025 Issue date: 13 Feb 2020
Application
Utility: AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND METHODS OF USE THEREOF External link
Filling date: 7 Sep 2025 Issue date: 6 Feb 2020
Application
Utility: SUBSTITUTED FUSED BI- OR TRI- HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS External link
Filling date: 7 Sep 2025 Issue date: 6 Feb 2020
Application
Utility: COMBINATION THERAPY FOR TREATING CANCER External link
Filling date: 7 Sep 2025 Issue date: 30 Jan 2020
Application
Utility: PRMT5 INHIBITORS AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 23 Jan 2020
Application
Utility: EZH2 INHIBITORS FOR TREATING LYMPHOMA External link
Filling date: 7 Sep 2025 Issue date: 23 Jan 2020
Application
Utility: INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF External link
Filling date: 7 Sep 2025 Issue date: 16 Jan 2020
Application
Utility: METHOD FOR TREATING CANCER External link
Filling date: 7 Sep 2025 Issue date: 9 Jan 2020
Application
Utility: TREATMENT OF LEUKEMIA VIA THE ADMINISTRATION OF DOT1L INHIBITOR PINOMETOSTAT External link
Filling date: 7 Sep 2025 Issue date: 9 Jan 2020
Grant
Utility: Combination therapy for treating cancer External link
Filling date: 7 Sep 2025 Issue date: 7 Jan 2020
Application
Utility: INJECTABLE FORMULATIONS FOR TREATING CANCER External link
Filling date: 7 Sep 2025 Issue date: 26 Dec 2019

Showing 50 to 100 of 122 patents.